EDIT Competitors & Alternatives
Compare Editas Medicine Inc with similar stocks in the same industry
Biotechnology
EDIT
Main Stock$3.26
Tradestie Score
56
Market Cap
$319.22M
Revenue Growth
-0.4%
Analyst Upside
+77.2%
Top Competitors
234 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CRVS
Corvus Pharmaceuticals, Inc.
|
$15.67
|
$540.97M | - | 60 | Compare |
|
PRTA
Prothena Corporation plc Ordinary Shares
|
$9.24
|
$533.99M | - | 57 | Compare |
|
ZVRA
Zevra Therapeutics, Inc. Common Stock
|
$13.35
|
$529.35M | 7.3 | 48 | Compare |
|
MNPR
Monopar Therapeutics Inc. Common Stock
|
$106.60
|
$522.78M | - | 52 | Compare |
|
LXRX
Lexicon Pharmaceuticals, Inc.
|
$2.22
|
$512.39M | - | 59 | Compare |
|
RIGL
Rigel Pharmaceuticals Inc. (New)
|
$42.55
|
$505.12M | 2.3 | 55 | Compare |
|
RGNX
REGENXBIO Inc.
|
$13.95
|
$493.52M | - | 59 | Compare |
|
INBX
Inhibrx Biosciences, Inc. Common Stock
|
$93.01
|
$492.21M | - | 57 | Compare |
|
XOMA
XOMA Royalty Corporation Common Stock
|
$44.22
|
$474.20M | 28.7 | 66 | Compare |
|
ABSI
Absci Corporation Common Stock
|
$10.60
|
$468.01M | - | 52 | Compare |
More EDIT Analysis
Data updated: Jul 12, 2026 | Industry: Biotechnology (SIC 2836)
234 stocks in this industry